vs
PMV Pharmaceuticals, Inc.（PMVP）与Rigetti Computing, Inc.（RGTI）财务数据对比。点击上方公司名可切换其他公司
Rigetti Computing, Inc.的季度营收约是PMV Pharmaceuticals, Inc.的1.5倍（$1.9M vs $1.2M），Rigetti Computing, Inc.净利率更高（-974.7% vs -1464.0%，领先489.4%），Rigetti Computing, Inc.同比增速更快（-17.9% vs -46.1%），PMV Pharmaceuticals, Inc.自由现金流更多（$-17.2M vs $-19.5M），过去两年Rigetti Computing, Inc.的营收复合增速更高（-21.8% vs -35.4%）
PMV Pharmaceuticals是一家临床阶段生物制药企业，专注于开发针对p53抑癌基因突变的精准肿瘤疗法，p53是人类癌症中最常见的突变基因之一。其在研管线主打产品用于治疗难治性实体瘤与血液恶性肿瘤，满足全球肿瘤患者未被满足的医疗需求。
Rigetti Computing总部位于美国加利福尼亚州伯克利，是专业的超导量子集成电路研发商，产品主要应用于量子计算机领域。公司还推出了名为Forest的云平台，支持开发者编写各类量子算法。
PMVP vs RGTI — 直观对比
营收规模更大
RGTI
是对方的1.5倍
$1.2M
营收增速更快
RGTI
高出28.3%
-46.1%
净利率更高
RGTI
高出489.4%
-1464.0%
自由现金流更多
PMVP
多$2.3M
$-19.5M
两年增速更快
RGTI
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2M | $1.9M |
| 净利润 | $-18.0M | $-18.2M |
| 毛利率 | — | 34.9% |
| 营业利润率 | -1561.8% | -1209.7% |
| 净利率 | -1464.0% | -974.7% |
| 营收同比 | -46.1% | -17.9% |
| 净利润同比 | 21.6% | 88.1% |
| 每股收益（稀释后） | $-0.33 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PMVPRGTI
| Q4 25 | $1.2M | $1.9M | ||
| Q3 25 | $1.5M | $1.9M | ||
| Q2 25 | $1.7M | $1.8M | ||
| Q1 25 | $1.9M | $1.5M | ||
| Q4 24 | $2.3M | $2.3M | ||
| Q3 24 | $2.6M | $2.4M | ||
| Q2 24 | $2.8M | $3.1M | ||
| Q1 24 | $3.0M | $3.1M |
净利润PMVPRGTI
| Q4 25 | $-18.0M | $-18.2M | ||
| Q3 25 | $-21.1M | $-201.0M | ||
| Q2 25 | $-21.2M | $-39.7M | ||
| Q1 25 | $-17.4M | $42.6M | ||
| Q4 24 | $-23.0M | $-153.0M | ||
| Q3 24 | $-19.2M | $-14.8M | ||
| Q2 24 | $-1.2M | $-12.4M | ||
| Q1 24 | $-15.3M | $-20.8M |
毛利率PMVPRGTI
| Q4 25 | — | 34.9% | ||
| Q3 25 | — | 20.7% | ||
| Q2 25 | — | 31.4% | ||
| Q1 25 | — | 30.0% | ||
| Q4 24 | — | 44.1% | ||
| Q3 24 | — | 50.6% | ||
| Q2 24 | — | 64.5% | ||
| Q1 24 | — | 49.1% |
营业利润率PMVPRGTI
| Q4 25 | -1561.8% | -1209.7% | ||
| Q3 25 | -1521.8% | -1055.4% | ||
| Q2 25 | -1353.8% | -1103.9% | ||
| Q1 25 | -1114.4% | -1469.6% | ||
| Q4 24 | -1100.5% | -813.3% | ||
| Q3 24 | -837.0% | -729.4% | ||
| Q2 24 | -720.1% | -521.2% | ||
| Q1 24 | -617.2% | -543.4% |
净利率PMVPRGTI
| Q4 25 | -1464.0% | -974.7% | ||
| Q3 25 | -1422.9% | -10321.9% | ||
| Q2 25 | -1255.0% | -2201.8% | ||
| Q1 25 | -901.1% | 2895.3% | ||
| Q4 24 | -1005.7% | -6726.5% | ||
| Q3 24 | -735.2% | -623.8% | ||
| Q2 24 | -43.3% | -402.5% | ||
| Q1 24 | -517.3% | -680.6% |
每股收益（稀释后）PMVPRGTI
| Q4 25 | $-0.33 | $-0.08 | ||
| Q3 25 | $-0.40 | $-0.62 | ||
| Q2 25 | $-0.41 | $-0.13 | ||
| Q1 25 | $-0.34 | $0.13 | ||
| Q4 24 | $-0.45 | $-0.80 | ||
| Q3 24 | $-0.37 | $-0.08 | ||
| Q2 24 | $-0.02 | $-0.07 | ||
| Q1 24 | $-0.30 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $112.9M | $44.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $104.7M | $546.2M |
| 总资产 | $116.6M | $666.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PMVPRGTI
| Q4 25 | $112.9M | $44.9M | ||
| Q3 25 | $129.3M | $26.1M | ||
| Q2 25 | $142.3M | $57.2M | ||
| Q1 25 | $160.4M | $37.2M | ||
| Q4 24 | $169.5M | $67.7M | ||
| Q3 24 | $182.8M | $20.3M | ||
| Q2 24 | $212.9M | $20.7M | ||
| Q1 24 | $197.9M | $35.1M |
股东权益PMVPRGTI
| Q4 25 | $104.7M | $546.2M | ||
| Q3 25 | $121.0M | $371.8M | ||
| Q2 25 | $140.6M | $553.3M | ||
| Q1 25 | $160.1M | $207.1M | ||
| Q4 24 | $176.1M | $126.6M | ||
| Q3 24 | $197.9M | $122.8M | ||
| Q2 24 | $214.3M | $122.2M | ||
| Q1 24 | $212.7M | $115.6M |
总资产PMVPRGTI
| Q4 25 | $116.6M | $666.6M | ||
| Q3 25 | $133.8M | $630.3M | ||
| Q2 25 | $152.9M | $636.7M | ||
| Q1 25 | $170.6M | $269.1M | ||
| Q4 24 | $191.3M | $284.8M | ||
| Q3 24 | $223.5M | $157.3M | ||
| Q2 24 | $237.5M | $162.4M | ||
| Q1 24 | $236.9M | $162.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-17.2M | $-14.9M |
| 自由现金流经营现金流 - 资本支出 | $-17.2M | $-19.5M |
| 自由现金流率自由现金流/营收 | -1396.4% | -1042.5% |
| 资本支出强度资本支出/营收 | 1.2% | 244.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-73.6M | $-77.2M |
8季度趋势，按日历期对齐
经营现金流PMVPRGTI
| Q4 25 | $-17.2M | $-14.9M | ||
| Q3 25 | $-19.8M | $-13.8M | ||
| Q2 25 | $-18.3M | $-16.2M | ||
| Q1 25 | $-18.3M | $-13.7M | ||
| Q4 24 | $-16.7M | $-8.5M | ||
| Q3 24 | $-16.8M | $-15.4M | ||
| Q2 24 | $-1.6M | $-13.5M | ||
| Q1 24 | $-16.2M | $-13.1M |
自由现金流PMVPRGTI
| Q4 25 | $-17.2M | $-19.5M | ||
| Q3 25 | $-19.8M | $-19.7M | ||
| Q2 25 | $-18.3M | $-21.8M | ||
| Q1 25 | $-18.3M | $-16.2M | ||
| Q4 24 | $-16.7M | $-9.8M | ||
| Q3 24 | $-16.8M | $-17.7M | ||
| Q2 24 | $-1.6M | $-15.6M | ||
| Q1 24 | $-16.8M | $-18.6M |
自由现金流率PMVPRGTI
| Q4 25 | -1396.4% | -1042.5% | ||
| Q3 25 | -1339.3% | -1012.4% | ||
| Q2 25 | -1083.6% | -1212.4% | ||
| Q1 25 | -944.2% | -1100.4% | ||
| Q4 24 | -731.0% | -432.1% | ||
| Q3 24 | -644.0% | -744.5% | ||
| Q2 24 | -57.2% | -504.3% | ||
| Q1 24 | -568.4% | -610.5% |
资本支出强度PMVPRGTI
| Q4 25 | 1.2% | 244.8% | ||
| Q3 25 | 0.1% | 302.5% | ||
| Q2 25 | 0.7% | 314.7% | ||
| Q1 25 | 0.2% | 173.0% | ||
| Q4 24 | 2.4% | 56.4% | ||
| Q3 24 | 0.0% | 95.8% | ||
| Q2 24 | 0.1% | 66.3% | ||
| Q1 24 | 20.1% | 180.0% |
现金转化率PMVPRGTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.32× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PMVP
暂无分部数据
RGTI
| Collaborative Research And Other Professional Services | $1.7M | 93% |
| Other | $131.0K | 7% |
